← Back to Search

Nutritional Supplement

Oral Nutritional Supplements for Malnutrition in Children

N/A
Waitlist Available
Research Sponsored by Abbott Nutrition
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Child is 36 months - 107 months of age
Be younger than 18 years old
Must not have
Child has been diagnosed with severe gastrointestinal disorders such as celiac disease, short bowel syndrome, pancreatic insufficiency, or cystic fibrosis
Child has been diagnosed with clinically significant nutritional deficiency requiring specialty nutritional therapy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 120 days
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if giving undernourished children a nutrient-rich drink along with healthy eating advice helps them grow better and become stronger.

Who is the study for?
This trial is for undernourished children aged 3-107 months in the U.S. whose caregivers agree to avoid non-study supplements and follow study procedures. Children with a normal height-for-age score, regular ONS use, acute infections, severe gastrointestinal disorders, hemoglobin disorders, or other significant medical conditions are excluded.
What is being tested?
The trial tests if taking a pediatric oral nutritional supplement (ONS) plus dietary counseling over 120 days improves growth and nutrition in undernourished children compared to just dietary counseling alone. It's randomized: some kids will get the ONS; others won't.
What are the potential side effects?
Potential side effects aren't specified but could include reactions to ingredients in the ONS for those with allergies or intolerances. Regular monitoring should identify any adverse effects from the supplement.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My child is between 3 and 9 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My child has a severe gastrointestinal disorder like celiac disease.
Select...
My child needs special nutrition due to a significant deficiency.
Select...
My child has a diagnosed blood disorder affecting hemoglobin.
Select...
My child has infantile anorexia, a developmental disability like cerebral palsy, or a severe developmental delay.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 120 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 120 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Weight-for-age z-score (WAZ)
Secondary study objectives
Anthropometric Measurement Calculations
Appetite
Dietary Diversity
+3 more
Other study objectives
Activity Data
Adverse Event Reporting
Caregiver Opinion Questionnaire
+9 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Oral Nutritional Supplement (ONS) GroupExperimental Treatment2 Interventions
Two servings per day in addition to dietary counseling
Group II: Control GroupExperimental Treatment1 Intervention
dietary counseling

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Oral nutritional supplements (ONS) work by providing a concentrated source of essential nutrients, including vitamins, minerals, proteins, and calories, which may be lacking in a malnourished patient's diet. These supplements support growth, improve nutritional status, and address nutrient deficiencies. For malnutrition patients, this is crucial as it promotes weight gain, enhances physical and cognitive development, and stabilizes overall health outcomes.

Find a Location

Who is running the clinical trial?

Abbott NutritionLead Sponsor
172 Previous Clinical Trials
33,619 Total Patients Enrolled
32 Trials studying Malnutrition
16,589 Patients Enrolled for Malnutrition
Jennifer Williams, MPHStudy ChairAbbott Nutrition
6 Previous Clinical Trials
641 Total Patients Enrolled

Media Library

Oral Nutritional Supplement (Nutritional Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT05161000 — N/A
Malnutrition Research Study Groups: Control Group, Oral Nutritional Supplement (ONS) Group
Malnutrition Clinical Trial 2023: Oral Nutritional Supplement Highlights & Side Effects. Trial Name: NCT05161000 — N/A
Oral Nutritional Supplement (Nutritional Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05161000 — N/A
~76 spots leftby Dec 2025